Workshop B: Strategic Enterprise Decision-Making, Challenges & Execution for Gene Therapy Expanded Access Programs

• Defining the Strategic Role of Expanded Access Across the Asset Lifecycle
• Structured Decision Framework to Determine Whether and When to Launch EAPs
• Considerations in Execution of Expanded Access Programs
• End to End Expanded Access Program execution processes

Speakers:

Kent Christopherson

Head, Global Medical Affairs

Orchard Therapeutics

Sheila Gilbride-Wilson

Vice President, Clinical Operations & Data Management

Orchard Therapeutics